NuCana plc (NCNA) Wins EU Composition Patent for NUC-7738

NuCana secured a European composition-of-matter patent (EP 3683225) for NUC-7738, adding to 85+ issued patents worldwide. NUC-7738 is in Phase 2 of a Phase 1/2 study, including a combo with Keytruda in PD-1 inhibitor—resistant metastatic melanoma.Material DetailsContext by AI AnalystThis is an IP s…